
Switzerland shows sustained growth of biotech sector
Capital investments in Swiss biotech companies reached the second-best amount ever with CHF3.33bn in the second year of the pandemic, according to...

Centauri Therapeutics starting with £24m financing
The financing round of the London-based immunotherapy specialist was led by Boehringer Ingelheim Venture Fund, Evotec SE, and Novo Holdings’ REPAIR...

Switzerland paves the way for genome editing
Following in the footsteps of the UK, Switzerland wants to exempt genome editing and targeted mutagenesis in plant breeding from the Swiss Genetic...

Curve Therapeutics in US$1.7bn deal with MSD
Under the contract, the Southampton-based mammalian cell drug discovery specialist will discover and validate modulators of up to five therapeutic...

New funds to boost European life sciences
Last November, LSP announced that it had raised €850m for LSP 7 and that it is intending to join forces with EQT, one of the largest European and...

Syndesi swallowed by Abbvie
Originally, Belgian Syndesi was created in 2017 through a partnership between UCB Biopharma SRL and a syndicate of Belgian and international...

Kurma Partners closes growth fund at €160m
The new fund is aimed at accelerating life sciences companies in advanced development stage, which is very similar to the recently presented EU...